Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Ovarian Neoplasms 3Mesothelioma, Malignant 3Carcinoma, Non-Small-Cell Lung 3Pancreatic Neoplasms 1Non Hematologic Cancers 1Neoplasms, Mesothelial 1Neoplasms 1Neoplasm Metastasis 1Mesothelioma 1Lung Neoplasms 1Low Grade Serous Ovarian Cancer 1Carcinoma, Ovarian Epithelial 1Adenoma 1

Interventions

defactinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Non Hematologic Cancers × defactinib × Clear all
NCT01943292 2017-03-09

Phase I Dose Escalation Study of VS-6063 in Japanese Subjects With Non-Hematologic Malignancies

Verastem, Inc.

Phase 1 Completed
9 enrolled 7 charts

Non Hematologic Cancers

Data powered by HemOnc (CC BY 4.0) Colophon âš¡